{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:18:03Z","timestamp":1793452683195,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012308","name":"National Jewish Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1136418"],"award-info":[{"award-number":["1136418"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1146128"],"award-info":[{"award-number":["1146128"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1159261"],"award-info":[{"award-number":["1159261"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.preghy.2021.07.243","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T08:30:34Z","timestamp":1627029034000},"page":"255-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast"],"prefix":"10.1016","volume":"25","author":[{"given":"Natasha","family":"de Alwis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie K.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M.","family":"Groom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Seeho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan C.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.preghy.2021.07.243_b0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The Global Impact of Pre-eclampsia and Eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin. Perinatol."},{"issue":"6","key":"10.1016\/j.preghy.2021.07.243_b0010","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","article-title":"Hypertensive disorders and severe obstetric morbidity in the United States","volume":"113","author":"Kuklina","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.07.243_b0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/siny.2000.0023","article-title":"Maternal and neonatal outcome in early- and late-onset pre-eclampsia","volume":"5","author":"Paruk","year":"2000","journal-title":"Semin Neonatol"},{"key":"10.1016\/j.preghy.2021.07.243_b0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertension"},{"issue":"8","key":"10.1016\/j.preghy.2021.07.243_b0025","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"9273","key":"10.1016\/j.preghy.2021.07.243_b0030","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(00)05112-6","article-title":"Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births","volume":"357","author":"Smith","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.preghy.2021.07.243_b0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/AOG.0b013e3181b7b242","article-title":"Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome","volume":"114","author":"Stekkinger","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.07.243_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.semperi.2014.03.003","article-title":"Long-term maternal morbidity and mortality associated with ischemic placental disease","volume":"38","author":"Adams","year":"2014","journal-title":"Semin. Perinatol."},{"issue":"1","key":"10.1016\/j.preghy.2021.07.243_b0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.bmb.a011609","article-title":"Fetal nutrition and cardiovascular disease in later life","volume":"53","author":"Barker","year":"1997","journal-title":"Br. Med. Bull."},{"issue":"4","key":"10.1016\/j.preghy.2021.07.243_b0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cvr\/cvu018","article-title":"Pre-eclampsia and cardiovascular disease","volume":"101","author":"Chen","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"9461","key":"10.1016\/j.preghy.2021.07.243_b0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.07.243_b0060","article-title":"Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia","author":"Tong","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2021.07.243_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","article-title":"Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders","volume":"69","author":"Mehta","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.preghy.2021.07.243_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.preghy.2021.07.243_b0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.108.122630","article-title":"Increased Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Expression in the Maternal Vasculature of Women With Preeclampsia","volume":"53","author":"Sankaralingam","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2021.07.243_b0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/01443615.2016.1269227","article-title":"Increased circulating oxidised low-density lipoprotein and antibodies to oxidised low-density lipoprotein in preeclampsia","volume":"37","author":"Arifin","year":"2017","journal-title":"J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.preghy.2021.07.243_b0085","doi-asserted-by":"crossref","first-page":"482.e1","DOI":"10.1016\/j.ajog.2009.05.032","article-title":"Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study","volume":"201","author":"Wiznitzer","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2021.07.243_b0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12944-017-0480-z","article-title":"Oxidative profiles of LDL and HDL isolated from women with preeclampsia","volume":"16","author":"Le\u00f3n-Reyes","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.preghy.2021.07.243_b0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.placenta.2004.05.012","article-title":"Expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: possible implications in the process of trophoblast apoptosis","volume":"26","author":"Lee","year":"2005","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.preghy.2021.07.243_b0100","doi-asserted-by":"crossref","first-page":"E1862","DOI":"10.1210\/jc.2012-1268","article-title":"Decreased Lectin-Like Oxidized LDL Receptor 1 (LOX-1) and Low Nrf2 Activation in Placenta Are Involved in Preeclampsia","volume":"97","author":"Chigusa","year":"2012","journal-title":"J. Clinical Endocrinology Metabolism"},{"issue":"8","key":"10.1016\/j.preghy.2021.07.243_b0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1369\/jhc.2008.950543","article-title":"Expression and localization of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in murine and human placentas","volume":"56","author":"Satoh","year":"2008","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.preghy.2021.07.243_b0110","first-page":"457","article-title":"Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion","volume":"69","author":"Onda","year":"2017","journal-title":"Decrease Hypertension, and Rescue Endothelial Dysfunction, Hypertension"},{"issue":"4","key":"10.1016\/j.preghy.2021.07.243_b0115","doi-asserted-by":"crossref","first-page":"388.e1","DOI":"10.1016\/j.ajog.2018.07.019","article-title":"Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial","volume":"219","author":"Cluver","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.07.243_b0120","doi-asserted-by":"crossref","unstructured":"Hypertension in Pregnancy: Executive Summary, Obstetrics & Gynecology 122(5) (2013).","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"issue":"5","key":"10.1016\/j.preghy.2021.07.243_b0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5694\/mja11.11331","article-title":"Australian national birthweight percentiles by sex and gestational age, 1998\u20132007","volume":"197","author":"Dobbins","year":"2012","journal-title":"Med. J. Aust."},{"issue":"1","key":"10.1016\/j.preghy.2021.07.243_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01605-x","article-title":"Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth","volume":"18","author":"Hannan","year":"2020","journal-title":"BMC Medicine"},{"issue":"4","key":"10.1016\/j.preghy.2021.07.243_b0135","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/HYPERTENSIONAHA.114.04781","article-title":"Sofalcone upregulates the nuclear factor (erythroid-derived 2)\u2013like 2\/heme oxygenase-1 pathway, reduces soluble fms\u2013like tyrosine kinase-1, and quenches endothelial dysfunction: Potential therapeutic for preeclampsia","volume":"65","author":"Onda","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2021.07.243_b0140","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.115.05847","article-title":"Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion","volume":"66","author":"Tong","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.preghy.2021.07.243_b0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.preghy.2014.09.003","article-title":"Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin","volume":"4","author":"Kaitu\u2019u-Lino","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"11","key":"10.1016\/j.preghy.2021.07.243_b0150","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2004-1028","article-title":"Hypoxia and sFlt-1 in preeclampsia: the \u201cchicken-and-egg\u201d question","volume":"145","author":"Karumanchi","year":"2004","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.preghy.2021.07.243_b0155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0143-4004(97)90000-X","article-title":"Oxygen and placental villous development: origins of fetal hypoxia","volume":"18","author":"Kingdom","year":"1997","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.preghy.2021.07.243_b0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000370195","article-title":"Inhibition of lectin-like oxidized low-density lipoprotein receptor 1 protects against plasma\/hypoxia-mediated trophoblast dysfunction associated with preeclampsia","volume":"79","author":"Zhang","year":"2015","journal-title":"Gynecol. Obstet. Invest."},{"issue":"6","key":"10.1016\/j.preghy.2021.07.243_b0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.placenta.2004.10.002","article-title":"Human placental explants in culture: Approaches and assessments","volume":"26","author":"Miller","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2021.07.243_b0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.placenta.2016.08.083","article-title":"Quality of placental RNA: Effects of explant size and culture duration","volume":"46","author":"Brew","year":"2016","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.preghy.2021.07.243_b0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-006-0375-1","article-title":"Effect of high oxygen on placental function in short-term explant cultures","volume":"328","author":"Reti","year":"2007","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.preghy.2021.07.243_b0180","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1210\/jc.2003-032042","article-title":"Oxidized Low-Density Lipoproteins Inhibit Trophoblastic Cell Invasion","volume":"89","author":"Pavan","year":"2004","journal-title":"J. Clinical Endocrinology Metabolism"},{"issue":"1","key":"10.1016\/j.preghy.2021.07.243_b0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/micc.12079","article-title":"Vascular Dysfunction in Preeclampsia","volume":"21","author":"Brennan","year":"2014","journal-title":"Microcirculation"},{"issue":"521","key":"10.1016\/j.preghy.2021.07.243_b0190","first-page":"e1","article-title":"Original Research: Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks\u2019 gestation","volume":"214","author":"Whitehead","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2021.07.243_b0195","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1038\/s41598-017-14180-8","article-title":"Placental trophoblast debris mediated feto-maternal signalling via small RNA delivery: implications for preeclampsia","volume":"7","author":"Wei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preghy.2021.07.243_b0200","unstructured":"Esomeprazole for the Prevention of Preeclampsia, https:\/\/ClinicalTrials.gov\/show\/NCT03717740."},{"key":"10.1016\/j.preghy.2021.07.243_b0205","unstructured":"Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial), https:\/\/ClinicalTrials.gov\/show\/NCT03213639."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921003172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921003172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:56:11Z","timestamp":1761897371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921003172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"alternative-id":["S2210778921003172"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.07.243","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.07.243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}